These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The role of aminochromes in ultraweak luminescence accompanying oxidative metabolism of catecholamines in model systems in vitro. Slawinska D; Slawinski J Physiol Chem Phys Med NMR; 1991; 23(4):247-60. PubMed ID: 1812504 [TBL] [Abstract][Full Text] [Related]
4. Iron chelation with salicylaldehyde isonicotinoyl hydrazone protects against catecholamine autoxidation and cardiotoxicity. Hašková P; Kovaříková P; Koubková L; Vávrová A; Macková E; Simůnek T Free Radic Biol Med; 2011 Feb; 50(4):537-49. PubMed ID: 21147217 [TBL] [Abstract][Full Text] [Related]
5. Cardioprotective effects of iron chelator HAPI and ROS-activated boronate prochelator BHAPI against catecholamine-induced oxidative cellular injury. Hašková P; Jansová H; Bureš J; Macháček M; Jirkovská A; Franz KJ; Kovaříková P; Šimůnek T Toxicology; 2016 Sep; 371():17-28. PubMed ID: 27744045 [TBL] [Abstract][Full Text] [Related]
7. Comparison of various iron chelators used in clinical practice as protecting agents against catecholamine-induced oxidative injury and cardiotoxicity. Hašková P; Koubková L; Vávrová A; Macková E; Hrušková K; Kovaříková P; Vávrová K; Simůnek T Toxicology; 2011 Nov; 289(2-3):122-31. PubMed ID: 21864640 [TBL] [Abstract][Full Text] [Related]
8. Cardiotoxicity of adrenochrome in isolated rabbit hearts assessed by epicardial NADH fluorescence. Rump AF; Klaus W Arch Toxicol; 1994; 68(9):571-5. PubMed ID: 7998824 [TBL] [Abstract][Full Text] [Related]
9. Influence of reducing agents on adrenochrome-induced changes in the heart. Singal PK; Yates JC; Beamish RE; Dhalla NS Arch Pathol Lab Med; 1981 Dec; 105(12):664-9. PubMed ID: 6895456 [TBL] [Abstract][Full Text] [Related]
10. Catecholamine-induced cardiotoxicity: A critical element in the pathophysiology of stroke-induced heart injury. Du Y; Demillard LJ; Ren J Life Sci; 2021 Dec; 287():120106. PubMed ID: 34756930 [TBL] [Abstract][Full Text] [Related]
11. Contribution of catecholamine reactive intermediates and oxidative stress to the pathologic features of heart diseases. Costa VM; Carvalho F; Bastos ML; Carvalho RA; Carvalho M; Remião F Curr Med Chem; 2011; 18(15):2272-314. PubMed ID: 21517751 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and analysis of aminochromes by HPLC-photodiode array. Adrenochrome evaluation in rat blood. Remião F; Milhazes N; Borges F; Carvalho F; Bastos ML; Lemos-Amado F; Domingues P; Ferrer-Correia A Biomed Chromatogr; 2003 Jan; 17(1):6-13. PubMed ID: 12582999 [TBL] [Abstract][Full Text] [Related]
13. Semiconductor properties of melanins prepared from catecholamines. Jastrzebska MM; Stepień K; Wilczok J; Porebska-Budny M; Wilczok T Gen Physiol Biophys; 1990 Aug; 9(4):373-83. PubMed ID: 2272486 [TBL] [Abstract][Full Text] [Related]
14. Biochemical and toxicological properties of the oxidation products of catecholamines. Bindoli A; Rigobello MP; Deeble DJ Free Radic Biol Med; 1992 Oct; 13(4):391-405. PubMed ID: 1398218 [TBL] [Abstract][Full Text] [Related]
15. Role of catecholamine oxidation in sudden cardiac death. Dhalla NS; Adameova A; Kaur M Fundam Clin Pharmacol; 2010 Oct; 24(5):539-46. PubMed ID: 20584205 [TBL] [Abstract][Full Text] [Related]
16. Pathophysiological mechanisms of catecholamine and cocaine-mediated cardiotoxicity. Liaudet L; Calderari B; Pacher P Heart Fail Rev; 2014 Nov; 19(6):815-24. PubMed ID: 24398587 [TBL] [Abstract][Full Text] [Related]
17. Prooxidant properties of vanadate in vitro on catecholamines and on lipid peroxidation by mouse and rat tissues. Donaldson J; LaBella F J Toxicol Environ Health; 1983 Jul; 12(1):119-26. PubMed ID: 6556257 [TBL] [Abstract][Full Text] [Related]
18. Oxidation chemistry of catecholamines and neuronal degeneration: an update. Napolitano A; Manini P; d'Ischia M Curr Med Chem; 2011; 18(12):1832-45. PubMed ID: 21466469 [TBL] [Abstract][Full Text] [Related]